JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma

Biomed Res Int. 2020 Sep 19:2020:7973568. doi: 10.1155/2020/7973568. eCollection 2020.

Abstract

Background: Stomach adenocarcinoma (STAD) is one of the most common malignant tumors. The Janus kinases (JAKs) play a significant part in cellular biological process, inflammation, and immunity. The roles of JAKs in STAD are still not systematically described.

Methods: A series of bioinformatics tools were used to clarify the role of JAKs in STAD.

Results: JAK3/TYK2 levels were significantly increased in STAD during subgroup analyses based on gender, tumor grade, cancer stages, and nodal metastasis status. STAD patients with high levels of JAK3/TYK2 had poor overall survival, postprogression survival, and first progression. Immune infiltration revealed a significant correlation between JAK3/TYK2 expression and the abundance of immune cells as well as immune biomarker expression in STAD. JAK3/TYK2 was associated with the adaptive immune response, chemokine signaling pathway, and JAK-STAT signaling pathway.

Conclusions: JAK3 and TYK2 serve as prognostic biomarkers and are associated with immune infiltration in STAD.

MeSH terms

  • Adenocarcinoma* / diagnosis
  • Adenocarcinoma* / genetics
  • Adenocarcinoma* / pathology
  • Biomarkers, Tumor / genetics
  • Female
  • Humans
  • Janus Kinase 3 / genetics*
  • Male
  • Neoplasm Invasiveness / diagnosis
  • Neoplasm Invasiveness / genetics
  • Neoplasm Invasiveness / pathology
  • Prognosis
  • Signal Transduction / genetics
  • Stomach Neoplasms* / diagnosis
  • Stomach Neoplasms* / genetics
  • Stomach Neoplasms* / pathology
  • TYK2 Kinase / genetics*

Substances

  • Biomarkers, Tumor
  • JAK3 protein, human
  • Janus Kinase 3
  • TYK2 Kinase
  • TYK2 protein, human